Literature DB >> 20080254

Can ARC save the heart?

Aaron M Abarbanell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20080254      PMCID： PMC2862837          DOI： 10.1016/j.jss.2009.07.016

Source DB:  PubMed          Journal:  J Surg Res        ISSN： 0022-4804            Impact factor:   2.192


× No keyword cloud information.
  5 in total

1.  ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases.

Authors:  T Koseki; N Inohara; S Chen; G Núñez
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

2.  Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress.

Authors:  Stefan Donath; Peifeng Li; Christian Willenbockel; Nidal Al-Saadi; Volkmar Gross; Thomas Willnow; Michael Bader; Ulrich Martin; Johann Bauersachs; Kai C Wollert; Rainer Dietz; Rüdiger von Harsdorf
Journal:  Circulation       Date:  2006-02-27       Impact factor: 29.690

3.  TAT protein transduction into isolated perfused hearts: TAT-apoptosis repressor with caspase recruitment domain is cardioprotective.

Authors:  Asa B Gustafsson; M Richard Sayen; Scott D Williams; Michael T Crow; Roberta A Gottlieb
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

4.  Blocking the development of postischemic cardiomyopathy with viral gene transfer of the apoptosis repressor with caspase recruitment domain.

Authors:  Subhasis Chatterjee; Lawrence T Bish; Vasant Jayasankar; Allan S Stewart; Y Joseph Woo; Michael T Crow; Timothy J Gardner; H Lee Sweeney
Journal:  J Thorac Cardiovasc Surg       Date:  2003-06       Impact factor: 5.209

5.  Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin.

Authors:  Wei-Qi Tan; Jian-Xun Wang; Zhi-Qiang Lin; Yan-Rui Li; Yu Lin; Pei-Feng Li
Journal:  Circulation       Date:  2008-11-10       Impact factor: 29.690
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.